NMPA (China) Releases Draft Regulation on Cosmetic Safety Risk Management for Public Consultation

The National Medical Products Administration (NMPA) announced the release of the “Measures for Monitoring and Administration of Cosmetic Safety Risks (Draft)” on September 14, 2024, for public consultation. This draft regulation is designed to strengthen the monitoring, analysis, and management of risk factors that could affect the safety and quality of cosmetics. It aligns with the “Regulations on the Supervision and Administration of Cosmetics” and the “Measures for the Supervision and Administration of Cosmetics Production and Operation.” The draft introduces systematic risk monitoring activities, such as inspections, testing, and early warning systems, to help identify and mitigate potential risks in cosmetics.

The regulation aims to provide a scientific basis for quality standards and risk control measures, contributing to the overall safety of cosmetics. Key aspects of the draft include sampling inspections, risk communication, and a national risk monitoring plan, structured across six parts: general provisions, planning, sampling and inspection, investigation and processing, application of monitoring results, and supplementary provisions.

The public consultation for the draft is open until October 8, 2024, offering stakeholders the opportunity to provide feedback. Businesses in the cosmetics sector should carefully review the draft, assess how it may impact their operations, and consider submitting feedback. The draft is expected to enhance the safety and quality of cosmetic products, potentially influencing all product categories, and businesses should begin preparing for compliance by evaluating their risk monitoring and safety protocols.